Three companies representing San Diego’s booming biotech sector are now marching into the middle of the battle to slow the spread of COVID-19. The National Institutes of Health has given San Diego’s Quidel Corp. a $71 million contract to expand its product used for onsite, or point of care, testing, the federal agency announced recently. […]
